Group 4F: Detection/Diagnosis



Thursday, Dec 15
10:00 am – 11:30 am Eastern Time (US/New York)



Poster #P1-05-07

Detection of progression or regression of breast cancer by circulating tumor DNA (ctDNA)

Poster #P1-05-33:

RNA in extracellular vesicles used for the prediction of distant metastasis of breast cancer and the function of TGM2 in promoting breast cancer development

Mentor: Stephanie Walker, R.N.

Stephanie Walker was diagnosed in July 2015 with de novo MBC. A retired RN with close to 40 years of clinical practice and 3 years teaching in a Community College. Her experience has been pediatric and adult critical care working in level 1 trauma centers and critical access hospitals. The last 15 years of her nursing career were with Hospice care. She is a member of many organizations local and national based and a recipient of the Spirit to Impact award. She is also project lead on an initiative called BECOME (Black Experience of Clinical Trials and Opportunities of Meaningful Engagement), as part of the MBC Alliance. She is advocating for men and women in rural areas for equal access to quality healthcare, treatment modalities, and resources. She does not want anyone to feel alone, isolated, or defeated.

Twitter: @faceofstage4

Scientist: Pavitra Viswanath, Ph.D. Candidate

Pavitra grew up in Bangalore, India, and moved to the United States in 2016 to pursue her master’s degree in biomedical science in Dr. Faye Johnson’s lab at MD Anderson Cancer Center. With an ardent interest to study metastasis and the tumor microenvironment, she joined Dr. Alana Welm’s lab in 2019 as a PhD student. Her research is focused on studying the vicious cycle of bone metastasis and characterizing the pro-metastatic components of the bone microenvironment that drive breast cancer metastasis. When she is not in the lab, she loves hiking, exploring, and taking pictures of the scenic spots in the mountains.

Twitter: @pviswanath93